Omacor

Omacor

Manufacturer:

Abbott

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Omega-3 acid ethyl esters 90 (EPA 460 mg, DHA 380 mg)
Indications/Uses
Adjuvant treatment in secondary prevention after MI in addition to other standard therapy (eg, statins, anti-platelet drugs, β-blockers, ACE inhibitors). Supplement to diet when dietary measures alone are insufficient to produce adequate response in monotherapy of type IV endogenous hypertriglyceridaemia or in combination therapy w/ statins in type IIb/III endogenous hypertriglyceridaemia when control of triglycerides is insufficient.
Dosage/Direction for Use
Post MI 1 cap daily. Hypertriglyceridaemia Initially 2 cap daily, may be increased up to 4 cap daily.
Administration
Should be taken with food.
Contraindications
Hypersensitivity to omega-3 ethyl esters or soya.
Special Precautions
Bleeding disorders or patients receiving anticoagulant therapy or other drugs affecting coagulation (eg, acetylsalicylic acid or NSAIDs). Monitor hepatic function (ASAT & ALAT) regularly in particular w/ high dosage (eg, 4 cap). Renal & hepatic impairment. Pregnancy. Childn. Elderly >70 yr.
Adverse Reactions
Dyspepsia, nausea; dizziness, dysgeusia, abdominal pain, hypersensitivity.
MIMS Class
Dyslipidaemic Agents / Other Cardiovascular Drugs
ATC Classification
C10AX06 - omega-3-triglycerides incl. other esters and acids ; Belongs to the class of other lipid modifying agents.
Presentation/Packing
Form
Omacor softgel cap 1,000 mg
Packing/Price
28's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in